IV Predictors | Subcategories | OR (95%CI) |
---|---|---|
Sex | Female | Ref |
 | Male | 1.28 (0.83-2.00) |
Contemporary Age |  | 0.96 (0.93–0.98) |
Age of illness onset | Â | 1.03 (1.00-1.06) |
BPRS-C | No/minimal symptoms (scores 18–30) | Ref |
 | Presence of clinically relevant symptoms (scores 31+) | 0.29 (0.13–0.65) |
Psychotropic polypharmacy | None or 1 type | Ref |
 | 2 + types | 1.19 (0.79–1.79) |
MADRS-C | No/minimal symptoms (scores 0–8) | Ref |
 | Presence of clinically relevant symptoms (scores 9+) | 0.92 (0.51–1.65) |
ITAQ-C | Low (scores 0–7) | Ref |
 | Medium (scores 8–13) | 2.03 (1.13–3.63) |
 | High (scores 14–22) | 2.65 (1.43–4.93) |
SDS-C Total |  | 0.99 (0.95–1.03) |
Consumer treatment satisfaction |  | 1.04 (0.82–1.32) |
Constant | Â | 0.27 |
Significance of model | Χ2(df, N) p-value | 61.455 (10, N = 739) p < 0.0005 |
Model percentage variance predicted | Between Cox & Snell R2 and Nagelkerke R2 | 8.0 − 13.5% |
Percentage of cases correctly classified | 83.5% |